Cite
MLA Citation
Karen C. Johnson et al.. “Tissue Factor Pathway Inhibitor, Activated Protein C Resistance, and Risk of Coronary Heart Disease Due To Combined Estrogen Plus Progestin Therapy.” Arteriosclerosis, thrombosis, and vascular biology, vol. 36, no. 2, 2016, p. . http://access.bl.uk/ark:/81055/vdc_100041945961.0x00000c